Aethlon Medical, Inc.
AEMD
$1.71
-$0.10-5.53%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.58M | 1.96M | 2.06M | 1.48M | 1.79M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.58M | 1.96M | 2.06M | 1.48M | 1.79M |
| Operating Income | -1.58M | -1.96M | -2.06M | -1.48M | -1.79M |
| Income Before Tax | -1.55M | -1.88M | -2.02M | -1.49M | -1.76M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.55M | -1.88M | -2.02M | -1.49M | -1.76M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.55M | -1.88M | -2.02M | -1.49M | -1.76M |
| EBIT | -1.58M | -1.96M | -2.06M | -1.48M | -1.79M |
| EBITDA | -1.51M | -1.88M | -1.98M | -1.40M | -1.71M |
| EPS Basic | -4.02 | -7.47 | -12.26 | -18.71 | -42.42 |
| Normalized Basic EPS | -2.51 | -4.75 | -7.66 | -11.43 | -26.52 |
| EPS Diluted | -4.02 | -7.47 | -12.26 | -18.71 | -42.42 |
| Normalized Diluted EPS | -2.51 | -4.75 | -7.66 | -11.43 | -26.52 |
| Average Basic Shares Outstanding | 384.70K | 252.20K | 164.60K | 79.50K | 41.50K |
| Average Diluted Shares Outstanding | 384.70K | 252.20K | 164.60K | 79.50K | 41.50K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |